Both in Pharmaceuticals
Ultragenyx Pharmaceutical vs Tyra Biosciences
Over the past year RARE returned −49.5% and TYRA returned +65.3%; their daily moves had a correlation of 0.20.
RARE −49.5% TYRA +65.3%Growth of $1, one year, split-adjusted
| Metric | RARE | TYRA |
|---|---|---|
| Price | $15.32 | $21.98 |
| Market cap | $1.51B | $1.51B |
| Today | +6.32% | +2.47% |
| 1 month | −40.2% | −11.9% |
| 6 months | −20.6% | −36.5% |
| Year to date | −33.4% | −16.4% |
| 1 year | −47.3% | +69.5% |
| Revenue growth (YoY) | +28.1% | — |
| Gross margin | 84.1% | — |
| Net margin | −43.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | — |
| Net cash | $292.0M | $353.9M |
| Dividend yield | — | — |
| Volatility (60d) | 127.9% | 87.6% |
| Short % of float | 17.7% | 29.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).